Safety and Exploratory Efficacy Study of NEUROSTEM® Versus Placebo in Patients With Alzheimer's Disease
NCT02054208
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
46
Enrollment
INDUSTRY
Sponsor class
Conditions
Alzheimer's Disease
Interventions
BIOLOGICAL:
human umbilical cord blood derived mesenchymal stem cells
OTHER:
Normal saline 2mL
Sponsor
Medipost Co Ltd.